Nurix Therapeutics, Inc. NRIX Unrealized Losses on Investments (Before Tax)
Unrealized Losses on Investments (Before Tax) at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s unrealized losses on investments (before tax).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s unrealized losses on investments (before tax)?
- Nurix Therapeutics, Inc. (NRIX) reported unrealized losses on investments (before tax) of $32K in Q4 2025.
- What does unrealized losses on investments (before tax) mean?
- This represents the cumulative negative change in the fair value of available-for-sale investment securities relative to their cost basis, calculated before accounting for tax impacts. It serves as a measure of market-driven depreciation in the company's investment portfolio. Monitoring this helps investors assess the volatility and risk exposure of the company's cash equivalents and short-term investments.